<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0"><channel><title>中外製薬トピックス</title><link>https://www.chugai-pharm.co.jp/news/</link><description>中外製薬の最新トピック情報</description><docs>http://www.rssboard.org/rss-specification</docs><generator>python-feedgen</generator><language>ja</language><lastBuildDate>Thu, 29 Jan 2026 02:39:20 +0000</lastBuildDate><item><title>【2026-01-28】抗CTLA-4スイッチ抗体ROSE12、非臨床研究の成果がJournal for ImmunoTherapy of Cancerに掲載 </title><link>https://www.chugai-pharm.co.jp/news/detail/20260128153000_1554.html?year=2026&amp;category=</link><description>抗CTLA-4スイッチ抗体ROSE12、非臨床研究の成果がJournal for ImmunoTherapy of Cancerに掲載</description><guid isPermaLink="false">https://www.chugai-pharm.co.jp/news/detail/20260128153000_1554.html?year=2026&amp;category=#20260128</guid><pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate></item><item><title>【2026-01-28】テセントリク、MRD陽性膀胱がんの術後補助療法に対し適応拡大申請 </title><link>https://www.chugai-pharm.co.jp/news/detail/20260128153001_1558.html?year=2026&amp;category=</link><description>テセントリク、MRD陽性膀胱がんの術後補助療法に対し適応拡大申請</description><guid isPermaLink="false">https://www.chugai-pharm.co.jp/news/detail/20260128153001_1558.html?year=2026&amp;category=#20260128</guid><pubDate>Wed, 28 Jan 2026 00:00:00 +0000</pubDate></item></channel></rss>